Breaking News

Arran Chemical Completes First Phase of “ADAPT” Expansion

Expands selectAZyme enzyme platform to include over 4,000 unique enzymes

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Arran Chemical Co., a provider of fine chemicals and pharmaceutical intermediates, has completed the first phase of its ADAPT (Arran Deploys Advanced Production Technologies) expansion with a multi-million investment and application of its selectAZyme technology.    Acquired by the Almac Group in November 2015, Arran has completed the first phase of a sustained investment program. Manufacturing plant assets have been upgraded with the installation and qualification of a new 6,300 L glass lined...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters